公开(公告)号：US11938161B2

公开(公告)日：2024-03-26

申请号：US17560772

申请日：2021-12-23

申请人： Liwei Sun

发明人： Liwei Sun ,  Rui Jiang ,  Daqing Zhao ,  Xiaohao Xu ,  Xuenan Chen ,  Jianzeng Liu ,  Rui Ma

IPC分类号： A61K36/258 ,  A61K36/074 ,  A61K36/076 ,  A61K36/14 ,  A61K36/254 ,  A61K36/287 ,  A61K36/48 ,  A61K36/484 ,  A61K36/725 ,  A61K36/744 ,  A61K36/79 ,  A61K36/896 ,  A61K36/8967 ,  A61P25/20

CPC分类号： A61K36/258 ,  A61K36/074 ,  A61K36/076 ,  A61K36/14 ,  A61K36/254 ,  A61K36/287 ,  A61K36/48 ,  A61K36/484 ,  A61K36/725 ,  A61K36/744 ,  A61K36/79 ,  A61K36/896 ,  A61K36/8967 ,  A61P25/20 ,  A61K2236/13 ,  A61K2236/333 ,  A61K2236/37 ,  A61K2236/53

摘要： The present disclosure belongs to the technical field of health care products or foods and provides the use of a ginseng alcohol extract in sleep-promoting health care products or foods. Through analysis utilizing DAM2 drosophila behavior monitoring system, it is found that the ginseng alcohol extract can increase total sleep duration of normal and sleep deprived drosophilae, and relieve sleep rhythm disorder caused by sleep deprivation. Through a climbing experiment, it is found that the ginseng alcohol extract can improve the climbing ability of normal and sleep deprived drosophilae. The ginseng alcohol extract, on the one hand, improves the quality of sleep to protect the steady state of sleep rhythm, and on the other hand, increases the motive ability after sleep. The ginseng alcohol extract of the present disclosure is intended to be used to sleep-promoting health care products or healthy foods and improve the quality of sleep.

公开(公告)号：US20240050503A1

公开(公告)日：2024-02-15

申请号：US17817028

申请日：2022-08-03

申请人： Clare G. Harvey ,  Dori Naerbo

发明人： Clare G. Harvey ,  Dori Naerbo

IPC分类号： A61K36/14 ,  A61K36/73 ,  A61K9/06 ,  A61K35/06 ,  A61K36/738 ,  A61K36/752

CPC分类号： A61K36/14 ,  A61K36/73 ,  A61K9/06 ,  A61K35/06 ,  A61K36/738 ,  A61K36/752

摘要： A method can relate to the use of flower essence-containing medicaments, particularly those that are useful for the alleviation of stress. More particularly, though not exclusively, a method can relate to topical applications including creams, such as facial and body cream, oils, spritzers and toners and serums, for oral and/or external application, that are useful for the alleviation of stress. Compositions provide a combination of advantageous properties of a cosmetic composition including one or more of Appearance, Odour, Ease of Application, Ease of Absorbency, Absorbency time, Greasiness (lower score if greasier), Irritation, Skin, Feel (softness) and Skin Moisturisation. Compositions can include one or more plant stem cell extracts in combination with one or more flower essences. A composition can preferably include extracts from Fitzroya cupressoide.

公开(公告)号：US11813287B1

公开(公告)日：2023-11-14

申请号：US18120305

申请日：2023-03-10

申请人： KING FAISAL UNIVERSITY

发明人： Hany Mohamed Abd El-Lateef Ahmed ,  Saadeldin Elsayed Ibrahim Shabaan ,  Jihad Wadai Saleh Alessa

IPC分类号： A61K33/26 ,  A61K31/245 ,  A61K36/14 ,  A61K9/12 ,  A61K36/54 ,  A61K47/46

CPC分类号： A61K33/26 ,  A61K9/12 ,  A61K31/245 ,  A61K36/14 ,  A61K36/54 ,  A61K47/46

摘要： Covid-19 binding aerosols are provided. The Covid-19 binding aerosols include Fe3O4 microparticles, at least one organoselenium compound, at least one essential oil, and incense. The Covid-19 binding aerosols may be formulated for use in any product that is capable of emitting aerosols, including but not limited to as air fresheners, as incense, or the like. The Fe3O4 microparticles may have an average size of 5,000 nm-10,000 nm (between 5-10 μm). The Covid-19 binding aerosols are formulated as aerosol compositions having an average size of greater than 60 μm-100 μm to ensure effective binding to virions.

公开(公告)号：US11304894B2

公开(公告)日：2022-04-19

申请号：US16866454

申请日：2020-05-04

申请人： Garrett E. Wdowin

发明人： Garrett E. Wdowin

IPC分类号： A61K9/00 ,  A61K36/30 ,  A61F13/472 ,  A61K9/70 ,  A61K33/06 ,  A61K31/675 ,  A61K31/519 ,  A61K33/22 ,  A61K47/02 ,  A61K31/07 ,  A61K31/355 ,  A61K35/747 ,  A61K36/888 ,  A61K36/886 ,  A61K36/63 ,  A61K36/14 ,  A61K36/61 ,  A61F13/20

摘要： Disclosed herein are compositions, delivery devices and methods for feminine health. A delivery device for feminine health can include a feminine hygiene product including an absorbent substrate and a composition absorbed onto the absorbent substrate for placement against a vulva, inserted into a vagina, or both. The composition can include a continuous phase and a dispersed phase dispersed throughout the continuous phase forming a fluid suspension. The continuous phase can include a solvent of one or more essential oils, one or more lubricants, or a combination thereof. The continuous phase can include one or more solutes dissolved in the solvent including one or more fat-soluble vitamins. The dispersed phase can include a pH-balancing agent, a dietary mineral, an absorbent, one or more water-soluble vitamins, or a combination thereof.

公开(公告)号：US20220110977A1

公开(公告)日：2022-04-14

申请号：US17556650

申请日：2021-12-20

申请人： Reza Saadat Niaki Moghaddam ,  Jayesh Arvind Desai

发明人： Reza Saadat Niaki Moghaddam ,  Jayesh Arvind Desai

IPC分类号： A61K35/26 ,  A61K36/481 ,  A61K35/28 ,  A61K36/9066 ,  A61K35/20 ,  A61K31/375 ,  A61K36/07 ,  A61K36/254 ,  A61K36/185 ,  A61K36/74 ,  A61K38/40 ,  A61K36/484 ,  A61K36/63 ,  A61K36/19 ,  A61K36/81 ,  A61K35/644 ,  A61K36/074 ,  A61K36/738 ,  A61K31/715 ,  A61K31/706 ,  A61K38/38 ,  A61K36/28 ,  A61K36/04 ,  A61K36/537 ,  A61K36/14 ,  A61K31/716 ,  A61K31/355 ,  A61K36/489 ,  A61K36/53 ,  A61K31/4045 ,  A61K33/06 ,  A61K31/7076 ,  A61K35/76 ,  A61K31/01 ,  A61K31/593 ,  A61K31/07 ,  A61K33/04 ,  A61K31/714 ,  A61K45/06 ,  A61K33/30 ,  A61K38/47 ,  A61K38/17 ,  A61P37/04

摘要： A pretreatment herbal composition comprises Andrographis paniculata, Eleuthero roots, and resistant potato starch. A treatment herbal composition comprises cannabidiol, bee pollen, and coconut oil, and in some embodiments, additionally comprises hemp seed oil. A fortifying herbal composition comprises many ingredients. A method comprises the steps of providing a dose of apitoxin at least once a day for at least one day, providing a dose of a glucosamine product at least once a day for at least one day, and providing a dose of a treatment herbal composition at least once a day for at least one day. In some embodiments, the method additionally comprises the step of providing a dose of a pretreatment herbal composition at least once a day for at least one day. In further embodiments, the method additionally comprises the step of providing a dose of a fortifying herbal composition.

公开(公告)号：US11298372B2

公开(公告)日：2022-04-12

申请号：US16885930

申请日：2020-05-28

申请人： National University Corporation Tokyo Medical and Dental University

发明人： Emi Nishimura ,  Hiroyuki Matsumura

IPC分类号： A61K31/713 ,  A61K38/55 ,  A61K36/05 ,  A61K36/14 ,  A61K36/47 ,  A61K36/48 ,  A61K36/54 ,  A61K8/97 ,  A61K31/506 ,  A61K36/489 ,  A61K36/738 ,  A61K36/04 ,  A61K36/424 ,  A61Q5/00 ,  A61K48/00 ,  A61K31/7088 ,  C12Q1/37 ,  A61K36/30 ,  A61K36/74 ,  A61K36/23 ,  A61K36/60 ,  A61K36/185 ,  A61Q7/00 ,  A61K36/718 ,  A61K36/488 ,  A61K36/53 ,  A61K36/82 ,  A61K39/395 ,  A61K36/18 ,  A61K36/28 ,  A61K31/222 ,  A61K45/00 ,  A61P17/14 ,  A61K31/05 ,  A61K31/16 ,  A61K31/355 ,  A61K31/375 ,  A61K31/381 ,  A61K31/7048 ,  A61K31/13 ,  A61K36/00

摘要： The present invention provides novel compositions for suppressing or improving hair loss, and compositions for suppressing or improving graying. More specifically, it provides agents that stabilize type XVII collagen expression, preferably agents that suppress the degradation of type XVII collagen by ELANE inhibitors and such, and compositions comprising a DNA repair-promoting agent or a DNA damage-suppressing agent as an active ingredient. Advantageous suppressive effects of hair loss and graying can be obtained when a composition comprising as an active ingredient a suppressive agent of type XVII collagen degradation such as an ELANE inhibitor is administered to a mammal. For the ELANE inhibitors, suppressive agents of type XVII collagen degradation and DNA repair-promoting agents, low-molecular compounds, polypeptides, proteins, antibodies, or nucleic acid medicine such as antisense oligos or siRNAs may be used. A method of screening for effective substances for suppression of hair loss and graying is also provided.

公开(公告)号：US10450210B2

公开(公告)日：2019-10-22

申请号：US15706053

申请日：2017-09-15

申请人： Riken Techno System Co., Ltd. ,  Santa Mineral Co., Ltd.

发明人： Koichi Furusaki

IPC分类号： C02F1/68 ,  A61K35/02 ,  A61K35/614 ,  A61K35/618 ,  A61K36/185 ,  A61K36/20 ,  A61K36/28 ,  A61K36/282 ,  A61K36/73 ,  A61K36/738 ,  C02F1/30 ,  C02F1/36 ,  C02F1/48 ,  A61K36/14

摘要： Provided is a method of producing mineral function water showing beneficial effects, such as antioxidant effects, or the like. The water including contains mineral-containing water (A) and mineral-containing water (B) according to a ratio of 1:5 to 1:20 (weight ratio), the mineral-containing water (A) containing first mineral components eluted from mineral-imparting material (A) containing: vegetation raw material, woody plant raw material, and sulfur raw material, the mineral-containing water (B) containing second mineral-containing water (B) containing the mineral component eluted from inorganic mineral-imparting material (B).

公开(公告)号：US10245295B1

公开(公告)日：2019-04-02

申请号：US15711125

申请日：2017-09-21

申请人： Laura Harris Smith

发明人： Laura Harris Smith

IPC分类号： A61K36/00 ,  A61K36/899 ,  A61K36/67 ,  A61K36/9068 ,  A61K36/53 ,  A61K36/14 ,  A61K36/328

摘要： This is a neurological essential oil composition employing oils containing sesquiterpene compounds that cross the blood-brain barrier, such as Vetiver, Black Pepper, Ginger, Ylang Ylang, Sandalwood, Patchouli, Cedarwood, Myrrh, Frankincense, or Lavender, offering calming relief from seizures, migraine, anxiety, tremor, PTSD, and other neurological ailments, minus side-effects often experienced with conventional neurotherapeutics. A case study using FDA guidelines was conducted on the composition by the inventor/nutritionist treating these disorders and more with success, including her own seizure disorder. For neurological stimulation to improve cognitive function, the composition recruits oils such as Coffee, Vanilla, Cinnamon Bark, Clove, Dalmatian Sage, Rosemary, Blood Orange, Lemon, Grapefruit, Peppermint, Lime, Clementine, Spearmint or Coconut. The invention is applied directly to the skin and is also present in other topical administrations such as shampoo, conditioner, lotion, face wash, body wash, bath salts, and in aromatherapy administrations such as candles, nasal inhalers and sprays.

公开(公告)号：US20190083564A1

公开(公告)日：2019-03-21

申请号：US15711125

申请日：2017-09-21

申请人： Laura Harris Smith

发明人： Laura Harris Smith

IPC分类号： A61K36/899 ,  A61K36/67 ,  A61K36/9068 ,  A61K36/53 ,  A61K36/14 ,  A61K36/328

摘要： This is a neurological essential oil composition employing oils containing sesquiterpene compounds that cross the blood-brain barrier, such as Vetiver, Black Pepper, Ginger, Ylang Ylang, Sandalwood, Patchouli, Cedarwood, Myrrh, Frankincense, or Lavender, offering calming relief from seizures, migraine, anxiety, tremor, PTSD, and other neurological ailments, minus side-effects often experienced with conventional neurotherapeutics. A case study using FDA guidelines was conducted on the composition by the inventor/nutritionist treating these disorders and more with success, including her own seizure disorder. For neurological stimulation to improve cognitive function, the composition recruits oils such as Coffee, Vanilla, Cinnamon Bark, Clove, Dalmatian Sage, Rosemary, Blood Orange, Lemon, Grapefruit, Peppermint, Lime, Clementine, Spearmint or Coconut. The invention is applied directly to the skin and is also present in other topical administrations such as shampoo, conditioner, lotion, face wash, body wash, bath salts, and in aromatherapy administrations such as candles, nasal inhalers and sprays.

公开(公告)号：US10201494B2

公开(公告)日：2019-02-12

申请号：US15893388

申请日：2018-02-09

申请人： Mary Kay Inc.

发明人： Tiffany Carle ,  David Gan ,  Michelle Hines

IPC分类号： A61K8/97 ,  A61Q19/02 ,  A61Q19/08 ,  A61Q17/04 ,  A61Q19/00 ,  A61K36/48 ,  A61K36/74 ,  A61K36/185 ,  A61K36/14 ,  A61K8/02

摘要： Disclosed is a topical skin composition and corresponding methods for its use that includes an extract from Phaseolus vulgaris, Citris sinensis, Wedelia trilobata, Burretiodendron hsienmu, Bauhinia brachycarpa var. cavaleriei, Cystacanthus paniculatus, Caesalpinia minax, Pueraria wallichii, Tetracentron sinense, Bridelia insulana, Hedyotis verticillata, Syzygium fruticosum, Cercidiphyllum japonicum, Bauhinia glauca, Rhododendron siderophyllum, Cudrania pubescens, Cajanus cajan, Wendlandia uvariifolia, Siegesbeckia glabrescens, Azolla imbricate, Juncus bufonius, Poikilospermum suaveolens, Clerodendrum trichotomum var. fargesii, Porandra ramosa, Annona glabra, Sterculia pexa, Phoebe puwenensis, Myriopteron extensum, Croton lachnocarpa, Dillenia turbinata, Alpinia blepharocalyx, Crotalaria spectabilis, Ficus lacor, Ravenala madagascariensis, Cocculus orbiculatus, Drynaria fortunei, Acrachne racemosa, Pseuderanthemum polyanthum, Eriobotrys serrata, Vernonia arborea, Adianthum caudatum, Phaseolus lunatus, Ipomoea cairica, Alopecurus aequalis, Arenga pinnata, Rhynchosia yunnanensis, Syzygium cumini, Clausena dunniana, Cyclosurus parasiticus, or Solanum carolinense.